Searchable abstracts of presentations at key conferences in endocrinology

ea0038p388 | Steroids | SFEBES2015

A novel animal model to explore the whole-organism response to 21-hydroxylase deficiency

Zaucker Andreas , Guran Tulay , Thakur Nazia , Taylor Angela , Griffin Aliesha , Krone Nils

Congenital adrenal hyperplasia (CAH) is one of the most common inherited disorders. The majority of CAH cases are due to 21-hydroxylase deficiency (21-OHD) caused by mutations in CYP21A2. Because of the profound impact of steroids on physiology and gene expression, the imbalances in steroid hormones resulting from 21-OHD are supposedly leading to a whole-organism response on transcriptome and metabolome level. The systemic consequences of severe 21-OHD during early development...

ea0038p392 | Steroids | SFEBES2015

Exploring metabolomic changes due to cortisol deficiency in early development using the ferredoxin (fdx1b) null-allele zebrafish

Weger Meltem , Griffin Aliesha , Goerling Benjamin , Taylor Angela E , Luy Burkhard , Mueller Ferenc , Krone Nils

Steroid hormones are important regulators of many physiological processes. The steroid precursor pregnenolone is converted through several enzymatic steps into all types of steroids, including the stress hormone cortisol. Mitochondrial steroidogenic cytochrome P450 (CYP) enzymes crucially relying on electron transfer from the redox partner ferredoxin (FDX1) are involved in key steps of the cortisol biosynthesis pathway.Cortisol is well-known regulator of...

ea0038p413 | Steroids | SFEBES2015

Profiling of multiple vitamin D metabolites in a healthy human cohort by high-throughput liquid chromatography–tandem mass spectrometry analysis

Jenkinson Carl , Taylor Angela , Susarla Radhika , Tamblyn Jennifer , Hassan-Smith Zaki , Keevil Brian , Hewison Martin

Although a complex metabolic pathway for vitamin D exists, serum measurement of inactive 25-hydroxyvitamin D3 (25OHD3) continues to be the most common determinant of vitamin D ‘status’. However, several other metabolites contribute to the physiological role of vitamin D, notably the active form 1α,25-dihydroxyvitamin D (1α,25(OH)2D3), inactive 3-epi-25OHD3 and chiral 23R and 24R,25(OH)2D3 metabolites. Quantification of these additional metabolites could pro...

ea0037oc5.4 | Steroids, developmental and paediatric endocrinology | ECE2015

Adipose tissue-specific androgen generation fuels an adverse metabolic phenotype in patients with polycystic ovary syndrome

O'Reilly Michael , Kempegowda Punith , Gathercole Laura , Taylor Angela , Bujalska Iwona , Tomlinson Jeremy , Arlt Wiebke

Insulin resistance and androgen excess are the cardinal features of polycystic ovary syndrome (PCOS). The severity of hyperandrogenism and metabolic dysfunction in PCOS are closely correlated, but underlying mechanisms remain poorly understood. Aldoketoreductase type 1C3 (AKR1C3) is an important source of adipose androgen generation, activating androstenedione to testosterone (T). We postulated that AKR1C3 plays a critical role linking androgen metabolism and...

ea0037gp.30.07 | Endocrine tumours and neoplasia – General | ECE2015

Steroid metabolome analysis reveals that prostate cancer has potent 5α-reductase, 3α- and 17β-hydroxysteroid dehydrogenase activities, but lacks 17-hydroxylase/17,20-lyase

Hofland Johannes , Taylor Angela E , Turgeman Orli , O'Neil Donna M , Foster Paul A , Arlt Wiebke

Introduction: Prostate cancer (PC) is dependent on androgen receptor (AR) activation by its canonical ligands testosterone and 5α-dihydrotestosterone (DHT). Intratumoural androgens persisting after castration give rise to castration-resistant PC (CRPC). These intraprostatic androgen levels are hypothesized to result from either adrenal androgen conversion or intratumoural de novo DHT synthesis through the classic or alternative pathways. Quantifying the steroid f...

ea0037ep1126 | Endocrine tumours | ECE2015

Oestrogen metabolism by steroid sulphatase and 17β-hydroxysteroid dehydrogenases promotes colorectal cancer proliferation via the G-protein coupled oestrogen receptor

Gilligan Lorna , Rahman Habibur , Hewitt Anne-Marie , Taylor Angela , Morton Dion , Foster Paul

Colorectal cancer (CRC) is the third most common cancer worldwide with incidence expected to rise. Although not traditionally viewed as a hormonal cancer, evidence suggests peripheral synthesis of active oestrogens worsens prognosis. Oestrogen metabolising enzymes include steroid sulphatase (STS), which desulphates oestrogens into their active forms, and 17β-hydroxysteroid dehydrogenases (17βHSD), which are estrogen oxidoreductase enzymes. We have previously shown ST...

ea0034s5.1 | Endocrine consequences of major trauma | SFEBES2014

The immune-endocrine mechanisms of trauma-induced sarcopenia

Hampson Peter , Foster Mark , Taylor Angela , Bentley Conor , Fallowfield Joanne , Midwinter Mark , Arlt Wiebke , Lord Janet

Advances in trauma care have improved survival resulting in more severely injured individuals surviving to enter the trauma care pathway. A significant threat to recovery is now the dysregulated immune response to injury. The hyperinflammatory response of the innate immune system (SIRS), combined with immunoparesis, leads to complications such as multi-organ failure and sepsis. Moreover, recovery from trauma is significantly affected by age, which may be due to changes in the ...

ea0034p353 | Steroids | SFEBES2014

A novel UPLC–MS/MS method to extract and quantify sulphated and non-sulphated oestrogens automatically optimised using MUSCLE software

Gilligan Lorna , Bradbury James , Taylor Angela , He Shan , O'Neil Donna , Viant Mark , Foster Paul

Oestradiol (E2) and oestrone (E1) are implicated in many diseases and drive cell proliferation in breast, ovarian, and endometrial cancer. Inactive sulphated oestrogens (E2S and E1S) represent a circulating reservoir forming active de-sulphated oestrogens. Therefore, new methods that accurately measure both sulphated and non-sulphated oestrogen concentrations have potential value for understanding oestrogen-related cancer. We present...

ea0033oc2.2 | Oral Communications 2 | BSPED2013

Increased bone area without reduction in volumetric bone mineral density in children treated with glucocorticoids for nephrotic syndrome

Moon Rebecca , Gilbert Rodney , Murphy Liam , Page Anna , Taylor Pat , Cooper Cyrus , Dennison Elaine , Davies Justin

Background: Glucocorticoids are frequently used to treat childhood inflammatory disorders, and may cause increased fracture predisposition with reduced bone mineral density (BMD), particularly from trabecular bone loss. The contribution of the underlying inflammatory disease processes to these outcomes is poorly understood. Childhood nephrotic syndrome (NS) is a useful model to investigate the effects of steroids on bone, as recurrent courses are often required, but systemic i...

ea0031oc2.2 | Steroids and thyroid | SFEBES2013

Abnormal cardiac bio-energetics in subclinical hypothyroidism; cardiac magnetic resonance spectroscopic study

Madathil Asgar , Hollingsworth Kieren , Razvi Salman , Blamire Andrew , Taylor Roy , Newton Julia , Weaver Jolanta

Background: It is well established that subclinical hypothyroidism (SCH) is associated with mild ventricular dysfunction and early cardiovascular disease (CVD), but it is unknown if there is an underlying defect in cardiac bio-energetic function.Objective: To quantify the cardiac phosphocreatine/ATP (PCr/ATP) ratio in SCH, compare with healthy controls (HC) and to measure the effect of 6 months of thyroxine treatment.Method: Cardia...